Treatment of inflammatory disorders of the bowel and urinary bladder
A technology for inflammation, disorders, applied in the field of treatment of inflammatory disorders of the bowel and bladder
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0051] Patients with ulcerative conjunctivitis treated with extracorporeal photochemotherapy.
[0052] I. Patient Population Description
[0053] Patients suffering from acute ulcerative colitis were the subjects of this clinical study. To qualify for this study plan, the following inclusion / exclusion criteria must be met:
[0054] - Patient must be 40 kg
[0055] - Female patients who are due to deliver must have a pregnancy urine test within 24 hours of study treatment. Effective birth control must be administered from one month prior to study treatment to the end of the program. Female patients cannot be lactating.
[0056] —Experimental value before the study:
[0057] ●WBC over 3.0 cmm
[0058] ●hemoglobin over 6.5mg / dL
[0059] ●Platelet count >75,000 / UL
[0060] ●The prothrombin time does not exceed the normal range of 3 seconds
[0061] — can provide informed consent
[0062] - Adequate venous access
[0063] - Able and willing to comply with research protoc...
Embodiment 2
[0175] Extracorporeal photochemotherapy in patients with Crohn's disease
[0176] I. Patient Population Description
[0177] Patients with acute Crohn's disease were the subjects of this clinical study. To qualify for this study plan, the following inclusion / exclusion criteria must be met:
[0178] A. Contains Standards
[0179] - Between the ages of 18 and 65
[0180] — Diagnosis of Crohn's disease based on Malchow's criteria and Crohn's activity index (CDAI)
[0181] - Radiographic and / or endoscopic and / or sonograph positioning records within 12 months prior to study start
[0182] - Steroid-dependent disorders must be documented on at least 10 mg prednisone daily for at least three months to achieve symptom remission (remission is defined as CDAI < 200 for two consecutive weeks). Steroid dependence must be confirmed by a history of at least one relapse in the event of an attempt to reduce the steroid dose to <10 mg.
[0183] - Satisfaction in writing or orally, with a...
Embodiment 3
[0258] Extracorporeal photochemical therapy for patients with interstitial cystitis
[0259] I. Patient Population Description
[0260] Patients suffering from acute interstitial cystitis were the subjects of this clinical study. To qualify for this study plan, the following inclusion / exclusion criteria must be met:
[0261] A. Contains Standards
[0262] - aged between 18 and 65
[0263] - Satisfaction in writing or orally, with a witness, after the patient has been fully informed by the treating physician
[0264] - Before starting treatment, all women of childbearing age must undergo a documented intrarectal β-HCG pregnancy test within 24 hours of the first treatment. In addition, they had to agree to receive an adequate form of contraception in the study.
[0265] - No known allergy to heparin or 8-methoxypsoralen.
[0266] - Patient must feel pain when the bladder is full and relief when it is empty
[0267] -and-
[0268] Patient must have suprapubic, pelvic, ure...
PUM
| Property | Measurement | Unit |
|---|---|---|
| wavelength | aaaaa | aaaaa |
| activation index | aaaaa | aaaaa |
| activation index | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More